PPARG and neuroblastoma: In the case of neuroblastoma, both PPARγ and PPARβ/δ ligands showed antiproliferative effects but it should be noted that PPARγ activation results in apoptosis promotion, while PPARβ/δ activation results in cell cycle arrest and neuronal differentiation, thus suggesting the possibility to use dual agonists to counteract tumor progression and recurrences.